[O2-4] SARS2-3

[O2-4-3] Investigation of SARS-CoV-2 Omicron BA.2 derived subvariants

*Izumi Kimura¹, Daichi Yamasoba^1,2, Tomokazu Tamura³, Naganori Nao^4,5, Jumpei Ito¹, Keita Matsuno^5,6,7, Hirofumi Sawa^4,5,8, Takasuke Fukuhara³, Kei Sato¹ (1. Department of Microbiology and Immunology, Division of Systems Virology, The Institute of Medical Science, The University of Tokyo, 2. Faculty of Medicine, Kobe University, 3. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, 4. Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, 5. One Health Research Center, Hokkaido University, 6. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, 7. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, 8. Division of molecular pathobiology, International Institute for Zoonosis Control, Hokkaido University)